Lung Cancer Update
By Dr. Neil Love
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dr. Neil Love
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 34
Reviews: 0
Episodes: 33
Description
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
| Episode | Date |
|---|---|
|
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit
|
May 18, 2025 |
|
EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit
|
Apr 30, 2025 |
|
Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
|
Apr 26, 2025 |
|
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
|
Apr 10, 2025 |
|
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Feb 06, 2025 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer
|
Dec 13, 2024 |
|
Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer
|
Dec 11, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences
|
Nov 25, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Lung Cancer
|
Nov 16, 2024 |
|
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences
|
Nov 07, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
|
Oct 23, 2024 |
|
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
|
Oct 16, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
|
Oct 08, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
|
Oct 02, 2024 |
|
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
|
Sep 19, 2024 |
|
Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Sep 12, 2024 |
|
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
|
Aug 21, 2024 |
|
Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
|
Aug 14, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
|
Aug 05, 2024 |
|
Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Jul 25, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
|
Jun 12, 2024 |
|
Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
|
Apr 04, 2024 |
|
Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
|
Mar 20, 2024 |
|
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
|
Dec 11, 2023 |
|
Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
|
Oct 16, 2023 |
|
Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
|
Sep 08, 2023 |
|
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 22, 2023 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
|
May 01, 2023 |
|
Recent Advances and Future Directions in Lung Cancer — With Dr Ibiayi Dagogo-Jack and Stephen Liu (Proceedings from a Symposium in Partnership with NCOA and SCOS)
|
Mar 17, 2023 |
|
Striving for Consensus on the Management of ALK-Positive Lung Cancer
|
Mar 06, 2023 |
|
Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer?
|
Feb 21, 2023 |
|
Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
|
Feb 13, 2023 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
|
Jan 24, 2023 |